(Medical Xpress)—An international team of researchers has discovered a way to silence the genes that cause transthyretin amyloidosis—a fatal genetic disease. In their paper published in the New England Journal of Medicine, the team describes how they developed a new treatment called ALN-TTR02 to prevent the creation in the body of a type of protein that causes problems in patient's nerves and heart.
↧